- List
- By Topic
- On Map
- Search Details

"Diabetic Nephropathies"
Need help? See RSS Feeds
Choose a feed type:

"Diabetic Nephropathies" (302 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02517320 | Completed | Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
293 | All | 20 Years to 75 Years (Adult, Senior) | NCT02517320 | MT-3995-J05 | July 2015 | November 2016 | January 2017 | August 7, 2015 | March 3, 2017 |
|
||
2 | NCT02205372 | Completed | Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
31 | All | 20 Years to 75 Years (Adult, Senior) | NCT02205372 | MT-3995-J04 | July 2014 | August 2015 | August 2015 | July 31, 2014 | September 16, 2015 |
|
||
3 | NCT02204280 | Completed | The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy |
|
Observational |
|
Other |
|
|
120 | All | 18 Years to 70 Years (Adult, Senior) | NCT02204280 | HebeiMUTH | August 2014 | July 2015 | July 2015 | July 30, 2014 | July 21, 2015 | |||||
4 | NCT01889277 | Completed | Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
51 | All | 20 Years to 75 Years (Adult, Senior) | NCT01889277 | MT-3995-J03 | July 2013 | January 2015 | January 2015 | June 28, 2013 | January 27, 2015 |
|
||
5 | NCT03436693 | Recruiting | Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
300 | All | 30 Years and older (Adult, Senior) | NCT03436693 | TA-7284-14 | February 15, 2018 | September 2021 | September 2021 | February 16, 2018 | April 5, 2018 |
|
||
6 | NCT02704494 | Completed | Resveratrol's Effects in Diabetic Nephropathy |
|
|
Interventional | Early Phase 1 |
|
Other |
|
|
60 | All | 18 Years to 70 Years (Adult, Senior) | NCT02704494 | 93-01-49-9028 | ReDNeph | March 2016 | February 2017 | February 2017 | March 10, 2016 | October 5, 2017 |
|
|
7 | NCT03407989 | Recruiting | SWIDINEP a Swiss Diabetic Nephropathy Cohort |
|
Observational |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Senior) | NCT03407989 | CER 43/12 | SWIDINEP | January 1, 2014 | January 1, 2022 | January 1, 2022 | January 23, 2018 | January 24, 2018 |
|
|||
8 | NCT03147677 | Recruiting | Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan |
|
|
Interventional | Phase 4 |
|
Other |
|
|
216 | All | 18 Years to 65 Years (Adult) | NCT03147677 | 320.6750.16025 | July 2016 | July 2018 | December 2018 | May 10, 2017 | October 25, 2017 |
|
||
9 | NCT01756703 | Completed | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
67 | All | 18 Years to 75 Years (Adult, Senior) | NCT01756703 | MT-3995-E06 | November 2012 | August 2014 | August 2014 | December 27, 2012 | February 9, 2015 |
|
||
10 | NCT01756716 | Completed | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
49 | All | 18 Years to 75 Years (Adult, Senior) | NCT01756716 | MT-3995-E07 | December 2012 | September 2014 | September 2014 | December 27, 2012 | February 9, 2015 |
|
||
11 | NCT03288571 | Not yet recruiting | Use of Wharton Jelly in Diabetic Nephropathy |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
20 | All | 35 Years to 70 Years (Adult, Senior) | NCT03288571 | DNJUCTC | January 2018 | December 2018 | April 2019 | September 20, 2017 | September 20, 2017 | |||
12 | NCT02442921 | Recruiting | Colchicine for Diabetic Nephropathy Trial |
|
|
Interventional | Phase 1 Phase 2 |
|
Other / Industry |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT02442921 | SHEBA-2015-1560-SK-CTIL | CDNT | February 22, 2016 | April 30, 2019 | April 30, 2019 | May 13, 2015 | May 9, 2017 |
|
|
13 | NCT03174821 | Completed | Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
160 | All | 18 Years to 70 Years (Adult, Senior) | NCT03174821 | IPT-OX-10 | October 20, 2010 | May 16, 2014 | May 16, 2014 | June 5, 2017 | June 5, 2017 | |||
14 | NCT02690883 | Unknown † | Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
90 | All | 18 Years to 70 Years (Adult, Senior) | NCT02690883 | ESR-14-10425 | March 2016 | March 2017 | October 2017 | February 24, 2016 | February 24, 2016 | |||
15 | NCT00317954 | Completed | Spironolactone in Diabetic Nephropathy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
48 | All | 18 Years and older (Adult, Senior) | NCT00317954 | 2612-2233 | September 2003 | July 2005 | April 25, 2006 | April 25, 2006 |
|
|||
16 | NCT02768948 | Not yet recruiting | Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy? |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Senior) | NCT02768948 | 16-AOI-09 | July 2016 | July 2018 | July 2018 | May 11, 2016 | May 12, 2016 | |||
17 | NCT00708981 | Completed | Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN) |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
120 | All | 18 Years to 70 Years (Adult, Senior) | NCT00708981 | Metabolism IST IRB# 06-177 |
May 2007 | October 2013 | December 2013 | July 3, 2008 | October 2, 2014 |
|
||
18 | NCT01005121 | Unknown † | Colchicine for Diabetic Nephropathy |
|
|
Interventional | Phase 2 |
|
Other |
|
|
12 | All | 18 Years to 90 Years (Adult, Senior) | NCT01005121 | SHEBA-09-7369-AL-CTIL | December 2009 | December 2014 | December 2015 | October 30, 2009 | January 4, 2013 |
|
||
19 | NCT00782847 | Completed | Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy |
|
|
Interventional | Phase 3 |
|
Other |
|
|
125 | All | 18 Years to 80 Years (Adult, Senior) | NCT00782847 | DiaNe-Studie | DiaNe | July 2004 | January 2007 | January 2007 | October 31, 2008 | October 31, 2008 |
|
|
20 | NCT01779089 | Unknown † | Minocycline and Proteinuria in Diabetic Nephropathy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT01779089 | 013400 | February 2009 | March 2016 | March 2016 | January 30, 2013 | May 21, 2015 |
|
||
21 | NCT02488252 | Recruiting | Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
148 | All | 35 Years to 80 Years (Adult, Senior) | NCT02488252 | DN-CM-1 | July 2015 | June 2018 | December 2018 | July 2, 2015 | October 26, 2016 |
|
||
22 | NCT01003236 | Completed | Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy |
|
|
Interventional | Phase 2 |
|
Other |
|
|
60 | All | 30 Years to 70 Years (Adult, Senior) | NCT01003236 | 4774 | October 2010 | October 2011 | November 2011 | October 28, 2009 | June 25, 2012 |
|
||
23 | NCT01858532 | Terminated | Study Of Diabetic Nephropathy With Atrasentan |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
5112 | All | 18 Years to 85 Years (Adult, Senior) | NCT01858532 | M11-352 2012-005848-21 |
SONAR | May 17, 2013 | March 29, 2018 | March 29, 2018 | May 21, 2013 | April 26, 2018 |
|
|
24 | NCT02410499 | Withdrawn | Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
0 | All | 18 Years to 90 Years (Adult, Senior) | NCT02410499 | MLN1202-2005 2014-005142-21 U1111-1168-1426 |
May 20, 2015 | November 17, 2015 | November 17, 2015 | April 7, 2015 | September 25, 2017 | |||
25 | NCT00967629 | Completed | Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy |
|
|
Interventional | Phase 1 |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Senior) | NCT00967629 | GCO 08-0976 | June 2009 | February 2010 | February 2010 | August 28, 2009 | November 18, 2011 |
|
||
26 | NCT01774981 | Completed Has Results |
Study of LY3016859 in Participants With Diabetic Nephropathy |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
60 | All | 18 Years to 75 Years (Adult, Senior) | NCT01774981 | 14353 I5V-MC-TGAB 2012-004496-40 |
March 2013 | August 2015 | August 2015 | January 24, 2013 | October 6, 2017 | August 15, 2017 |
|
|
27 | NCT00130312 | Terminated | Effect of Sulodexide in Overt Diabetic Nephropathy |
|
|
Interventional | Phase 4 |
|
Industry / Other |
|
|
1248 | All | 18 Years and older (Adult, Senior) | NCT00130312 | KRX-101-401 | August 2005 | March 2008 | March 2008 | August 15, 2005 | May 5, 2015 |
|
||
28 | NCT01796418 | Unknown † | Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
102 | All | 20 Years to 75 Years (Adult, Senior) | NCT01796418 | BESTinDN-001 | March 2013 | August 2014 | February 21, 2013 | December 16, 2013 |
|
|||
29 | NCT01935167 | Completed | To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
158 | All | 30 Years and older (Adult, Senior) | NCT01935167 | DW1029M | October 2013 | August 2014 | February 2015 | September 4, 2013 | February 17, 2017 |
|
||
30 | NCT01068041 | Completed | Effects of PH3 in Diabetic Nephropathy |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
100 | All | 18 Years to 70 Years (Adult, Senior) | NCT01068041 | PH-CP016 | PH3 | August 2010 | July 2014 | September 2015 | February 12, 2010 | November 4, 2015 |
|
|
31 | NCT00870402 | Unknown † | Aldosterone in Diabetic Nephropathy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
160 | All | 30 Years to 70 Years (Adult, Senior) | NCT00870402 | SA08I20032 | ALDODN | March 2009 | December 2009 | March 2010 | March 27, 2009 | March 27, 2009 |
|
|
32 | NCT01768611 | Completed | SLC2A1 Variants and Diabetic Nephropathy |
|
Observational |
|
Other |
|
|
449 | All | 11 Years and older (Child, Adult, Senior) | NCT01768611 | FMUSP-LIM25-001 | October 2004 | October 2012 | October 2012 | January 15, 2013 | January 16, 2013 |
|
||||
33 | NCT01273675 | Unknown † | An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy |
|
Observational |
|
Other |
|
100 | All | 30 Years to 75 Years (Adult, Senior) | NCT01273675 | 201008056R | September 2010 | January 10, 2011 | January 10, 2011 | ||||||||
34 | NCT00320060 | Completed | Effect of Pyridorin in Patients With Diabetic Nephropathy |
|
|
Interventional | Phase 2 |
|
Industry |
|
128 | All | 18 Years to 70 Years (Adult, Senior) | NCT00320060 | PYR-206 | October 2001 | January 2003 | April 27, 2006 | April 27, 2006 | |||||
35 | NCT01601236 | Completed Has Results |
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
34 | All | 18 Years and older (Adult, Senior) | NCT01601236 | QSC01-DN-01 | May 2012 | January 2016 | March 2016 | May 17, 2012 | August 21, 2017 | July 24, 2017 |
|
|
36 | NCT00320021 | Completed | Effect of Pyridorin in Patients With Diabetic Nephropathy |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
80 | All | 18 Years to 70 Years (Adult, Senior) | NCT00320021 | PYR-205/207 PYR-205 PYR-207 |
July 2002 | September 2003 | April 27, 2006 | April 27, 2006 | ||||
37 | NCT00565318 | Completed | Benfotiamine in Diabetic Nephropathy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
86 | All | 40 Years to 75 Years (Adult, Senior) | NCT00565318 | BENFO-1 NL17390.075.07 |
Benfo | December 2007 | June 2009 | June 2009 | November 29, 2007 | November 16, 2009 |
|
|
38 | NCT01163591 | Completed | To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy |
|
Observational |
|
Other |
|
|
100 | All | 21 Years to 75 Years (Adult, Senior) | NCT01163591 | CRE-2008.470-T | January 2009 | October 2009 | October 2009 | July 16, 2010 | October 12, 2015 |
|
||||
39 | NCT01109212 | Completed | The Effects of Bindarit in Diabetic Nephropathy |
|
|
Interventional | Phase 2 |
|
Industry / Other |
|
|
100 | All | 30 Years to 70 Years (Adult, Senior) | NCT01109212 | 004SC06084 2006-006191-38 |
March 2007 | November 2008 | December 2008 | April 23, 2010 | March 30, 2016 |
|
||
40 | NCT01252056 | Completed | A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
353 | All | 40 Years to 75 Years (Adult, Senior) | NCT01252056 | 260-09-805-01 | March 2010 | December 2012 | December 2012 | December 2, 2010 | May 8, 2013 |
|
||
41 | NCT00774904 | Completed | Adiponectin and Insulin Resistance in Diabetic Nephropathy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
80 | All | 18 Years and older (Adult, Senior) | NCT00774904 | ADPN | April 2007 | October 2007 | November 2007 | October 17, 2008 | October 20, 2008 |
|
||
42 | NCT02327754 | Completed | Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
60 | All | 20 Years to 75 Years (Adult, Senior) | NCT02327754 | FY1004 | UPWARD | December 2016 | December 2016 | December 30, 2014 | April 12, 2017 |
|
||
43 | NCT01968668 | Completed | Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
96 | All | 18 Years and older (Adult, Senior) | NCT01968668 | 16816 | October 2013 | October 2014 | November 2014 | October 24, 2013 | January 9, 2015 |
|
||
44 | NCT00340678 | Completed Has Results |
Renoprotection in Early Diabetic Nephropathy in Pima Indians |
|
|
Interventional | Phase 3 |
|
NIH |
|
|
170 | All | 18 Years to 65 Years (Adult) | NCT00340678 | 999995037 OH95-DK-N037 |
August 1995 | May 2012 | March 2014 | June 21, 2006 | July 24, 2014 | November 19, 2013 |
|
|
45 | NCT02676401 | Completed | An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
241 | All | 20 Years to 75 Years (Adult, Senior) | NCT02676401 | MT-3995-J06 | February 2016 | August 2017 | February 8, 2016 | September 18, 2017 |
|
|||
46 | NCT03284996 | Not yet recruiting | Doppler Ultrasound in Early Detection of Diabetic Nephropathy Type 2 Diabetes Mellitus. |
|
|
Observational |
|
Other |
|
|
80 | All | 25 Years to 65 Years (Adult) | NCT03284996 | DUDN | October 1, 2017 | April 30, 2019 | September 1, 2019 | September 15, 2017 | September 15, 2017 | ||||
47 | NCT00353600 | Completed | Delaying the Progression of Diabetic Nephropathy in Pima Indians |
|
Observational |
|
NIH | 25 | All | 18 Years to 65 Years (Adult) | NCT00353600 | 999994034 OH94-DK-N034 |
August 19, 1994 | August 16, 2011 | July 18, 2006 | July 2, 2017 |
|
|||||||
48 | NCT00664027 | Completed | Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
80 | All | 18 Years and older (Adult, Senior) | NCT00664027 | RTA 402-C-0801 | April 2008 | May 2009 | April 22, 2008 | December 3, 2012 |
|
|||
49 | NCT03165240 | Recruiting | This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 4 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
105 | All | 18 Years and older (Adult, Senior) | NCT03165240 | 1378-0008 2017-000563-32 |
October 5, 2017 | June 30, 2019 | June 30, 2019 | May 24, 2017 | April 20, 2018 |
|
||
50 | NCT00136188 | Completed | Nitric Oxide (NO) Activity and Diabetic Nephropathy |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
100 | All | 18 Years to 65 Years (Adult) | NCT00136188 | SFB 423 TP B5 | August 2009 | December 2011 | December 2011 | August 26, 2005 | June 19, 2012 |
|
† Study has passed its completion date and status has not been verified in more than two years.